Home/Filings/4/0001578563-22-000011
4//SEC Filing

Miller Joseph M 4

Accession 0001578563-22-000011

CIK 0001534120other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 6:06 PM ET

Size

5.3 KB

Accession

0001578563-22-000011

Insider Transaction Report

Form 4
Period: 2022-03-31
Miller Joseph M
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-03-31+20,23920,239 total
    Exercise: $0.72From: 2022-03-31Exp: 2032-03-31Common Stock (20,239 underlying)
Footnotes (1)
  • [F1]100% of the stock option will immediately vest on the date that it is granted.

Issuer

Avalo Therapeutics, Inc.

CIK 0001534120

Entity typeother

Related Parties

1
  • filerCIK 0001746372

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 6:06 PM ET
Size
5.3 KB